CEO: Jon P. Stonehouse

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Biocryst Pharmaceuticals Inc is a pharmaceutical company that designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in the infectious and inflammatory diseases. It has its focus on oral treatments for rare diseases.


Key numbers

Market Capitalization:428284020
Shares Outstanding: 154059000
Float: 152067787
Next Earning Date:2020-02-25
TTm EPS: -1.2132
TTm Dividend Rate:
200 days moving average:3.75
50 days moving average: 2.72
One day percent Change: -1.77



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,